NCT05822531

Brief Summary

This pilot study aims to examine the feasibility and acceptability of adding a cardiovascular health module to the existing Nurse Family Partnership (NFP) home visitation program delivered by trained nurses in the Northern Appalachian region of Central Pennsylvania.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

April 20, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
5 months until next milestone

Results Posted

Study results publicly available

May 29, 2025

Completed
Last Updated

May 29, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

March 24, 2023

Results QC Date

April 24, 2025

Last Update Submit

May 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility of Integrating a Cardiovascular Health Module to the Existing Nurse-Family Partnership (NFP) Home Visiting Program as Measured by Qualitative Feedback From Home Visitors.

    Feasibility will be determined good acceptability by NFP nurses as assessed qualitatively during group discussions. Nurses will use their experience as home visitors to provide feedback to study personnel on whether they are able to successfully integrate new visit content into their usual workflow. They will further give suggestions for future improvement after completion of this pilot study.

    6 months

Study Arms (1)

Maternal Cardiovascular health (CVH) Intervention

EXPERIMENTAL

The pilot maternal CVH intervention will be delivered by NFP partners starting as early as NFP program enrollment in the first trimester after confirmation of a viable pregnancy and no later than the 28th week of pregnancy and will continue up to 6 months postpartum. The visit schedule will be consistent with the NFP visit structure to deliver intervention content at regularly scheduled visits that are typically 60 minutes long (weekly visits for the first month following enrollment followed by twice monthly visits until delivery). The pilot study will include an enhanced behavioral component target decreased sedentary time and increase physical activity and utilizing a technology/monitoring component. All women be monitored using a wrist-worn actigraphy device to record daily activity, intermittent home blood pressure self-monitoring, intermittent home weight self-monitoring, and carbon monoxide monitoring administered by the NFP nurse.

Behavioral: Maternal CVH Intervention

Interventions

All participants will be enrolled into the intervention arm of this pilot study.

Maternal Cardiovascular health (CVH) Intervention

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant Women
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Nulliparous pregnant woman
  • Age ≥ 18 years old
  • Enrolled in and receiving the Nurse-Family Partnership program through the Geisinger Clinic or UPMC Home Health Care of Central PA
  • English speaking
  • Women with a singleton viable pregnancy confirmed by NFP home visitors
  • Access to reliable internet service required for data collection
  • A minimum of 5 women with use of nicotine containing products (cigarette, cigar, hookah, chewing tobacco, e-cigarette, patch) within the past 3 months

You may not qualify if:

  • Unable or unwilling to comply with the study visits and procedures
  • Participation in a concurrent interventional study
  • Diagnosis of cancer
  • A personal history of complex congenital heart disease
  • A fetus in the current pregnancy with known chromosomal abnormalities or birth defects inconsistent with survival to 2 years will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UPMC Home Health

Altoona, Pennsylvania, 16601, United States

Location

Geisinger

Danville, Pennsylvania, 17822, United States

Location

MeSH Terms

Conditions

Cardiovascular DiseasesSedentary Behavior

Condition Hierarchy (Ancestors)

Behavior

Results Point of Contact

Title
Ian Paul
Organization
Penn State College of Medicine

Study Officials

  • Ian M Paul, MD, MSc

    Penn State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: This pilot study is being conducted to inform feasibility of the next phase of this research project.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics and Public Health Sciences; Chief, Division of Academic General Pediatrics; Vice Chair of Faculty Affairs, Department of Pediatrics Affiliation: Penn State University

Study Record Dates

First Submitted

March 24, 2023

First Posted

April 20, 2023

Study Start

August 1, 2023

Primary Completion

June 30, 2024

Study Completion

December 31, 2024

Last Updated

May 29, 2025

Results First Posted

May 29, 2025

Record last verified: 2025-05

Locations